Content about Glycated hemoglobin

April 16, 2014

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge.

BALTIMORE — Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics and the elderly.

March 26, 2014

In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease, adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional CVD risk factors like smoking and cholesterol was associated with little improvement in the prediction of CVD risk, according to a study in the March 26 issue of JAMA.

CHICAGO — In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease, adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional CVD risk factors like smoking and cholesterol was associated with little improvement in the prediction of CVD risk, according to a study in the March 26 issue of JAMA.

April 10, 2013

Bartell Drugs will play a prominent role at a diabetes expo in Seattle this weekend, the retail pharmacy chain said Wednesday.

SEATTLE — Bartell Drugs will play a prominent role at a diabetes expo in Seattle this weekend, the retail pharmacy chain said Wednesday.

February 19, 2013

Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

NEW YORK — Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study.

November 29, 2012

Use of electronic health records 
improves medical outcomes among patients with diabetes, according to a recent study conducted by Kaiser Permanente.


Use of electronic health records 
improves medical outcomes among patients with diabetes, according to a recent study conducted by Kaiser Permanente.


November 16, 2012

Walgreens and Take Care Clinics on Friday announced the offer of free health testing for hemoglobin A1C and blood glucose at more than 3,000 U.S. locations through the end of November as part of American Diabetes Month and the Walgreens Way to Well Commitment.

DEERFIELD, Ill. — Walgreens and Take Care Clinics on Friday announced the offer of free health testing for hemoglobin A1C and blood glucose at more than 3,000 U.S. locations through the end of November as part of American Diabetes Month and the Walgreens Way to Well Commitment. 

October 19, 2012

Blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in Type 2 diabetes patients who do not take insulin, according to a study published in the September issue of Diabetes Technology & Therapeutics.

MILPITAS, Calif. — Blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in Type 2 diabetes patients who do not take insulin, according to a study published in the September issue of Diabetes Technology & Therapeutics.

October 3, 2012

A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

INDIANAPOLIS — A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

July 31, 2012

A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.

PRINCETON, N.J. — A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.

July 23, 2012

Extended use of the oral DPP-4 inhibitor linagliptin to lower blood-glucose levels by Type 2 diabetes patients is effective, according to a new study.

NEW YORK — Extended use of the oral DPP-4 inhibitor linagliptin to lower blood-glucose levels by Type 2 diabetes patients is effective, according to a new study.

A team of eight researchers — four of which work for drug maker Boehringer Ingelheim — examined 2,121 Type 2 diabetes patients that had taken part in four previous 24-week randomized, double-blind, placebo-controlled trials in order to monitor them for a further 78 weeks. The participants who took part in the extended trial came from 231 sites in 32 countries.

June 21, 2012

An integrated wellness team approach to diabetes care can help patients not only improve their condition, but also lower their prescription costs, according to new research presented at the American Association of Clinical Endocrinologists’ 21st annual Scientific and Clinical Congress in Philadelphia.


An integrated wellness team approach to diabetes care can help patients not only improve their condition, but also lower their prescription costs, according to new research presented at the American Association of Clinical Endocrinologists’ 21st annual Scientific and Clinical Congress in Philadelphia.


May 31, 2012

Walgreens-owned clinic operator Take Care Clinics now is offering three new diagnostic tests and administrative physicals — a move that also advances the Well at Walgreens strategy to enhance services as a community healthcare provider and transform to a health and daily living destination.

CONSHOHOCKEN, Pa. — Walgreens-owned clinic operator Take Care Clinics now is offering three new diagnostic tests and administrative physicals — a move that also advances the Well at Walgreens strategy to enhance services as a community healthcare provider and transform to a health and daily living destination.

The launch of these new services is based on input from patients, managed care organizations and healthcare providers on ways to help prevent the progression of disease and use the most appropriate point of care, the company said.

May 29, 2012

An integrated wellness team approach to diabetes care can help patients not only improve their condition, but also lower their prescription costs, according to new research presented at the American Association of Clinical Endocrinologists' 21st annual Scientific and Clinical Congress in Philadelphia.

PHILADELPHIA — An integrated wellness team approach to diabetes care can help patients not only improve their condition, but also lower their prescription costs, according to new research presented at the American Association of Clinical Endocrinologists' 21st annual Scientific and Clinical Congress in Philadelphia.

May 24, 2012

A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.

RIDGEFIELD, Conn. — A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.

Boehringer Ingelheim Pharmaceuticals and Eli Lilly announced Thursday results of a phase-3 trial of Tradjenta (linagliptin) in which 226 patients with Type 2 diabetes received 5 mg of the drug once per day or placebo.

April 11, 2012

MinuteClinic has announced that this spring it is offering a free monitoring visit for patients with diabetes to help keep their health in check between visits to a primary care provider.

WOONSOCKET, R.I. — MinuteClinic has announced that this spring it is offering a free monitoring visit for patients with diabetes to help keep their health in check between visits to a primary care provider.

The complimentary monitoring service, which is available seven days a week, is administered by a MinuteClinic nurse practitioner or physician assistant and includes:

  • Hemoglobin A1C and blood-glucose test (as needed);

  • Blood pressure check;

  • Body mass index (BMI);

March 15, 2012

Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

NEW YORK — Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

March 1, 2012

An investigational diabetes therapy made by Takeda helped lower HbA1C levels among patients with Type 2 diabetes, the drug maker said.

DEERFIELD, Ill. — An investigational diabetes therapy made by Takeda helped lower HbA1C levels among patients with Type 2 diabetes, the drug maker said.

February 16, 2012

Oral blood samples drawn from periodontal inflammation can be used to measure HbA1C levels, a factor that indicates a patient's diabetes status, according to a New York University study.

NEW YORK — Oral blood samples drawn from periodontal inflammation can be used to measure HbA1C levels, a factor that indicates a patient's diabetes status, according to a New York University study.

December 8, 2011

A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

INDIANAPOLIS — A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

Eli Lilly & Co. and Boehringer Ingelheim announced results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, presenting results at the International Diabetes Federation World Diabetes Conference in Dubai.

December 7, 2011

Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.

MOUNTAIN VIEW, Calif. — Obese diabetes patients could experience weight loss when taking Vivus' anti-obesity drug, according to an oral presentation at the International Diabetes Federation's World Diabetes Congress in Dubai.

November 23, 2011

An online data sharing platform announced it will debut a daily blood-glucose monitoring feature for its more than 2,000 diabetes patients.

CAMBRIDGE, Mass. — An online data sharing platform announced it will debut a daily blood-glucose monitoring feature for its more than 2,000 diabetes patients.

PatientsLikeMe said patients will be able to report daily glucose levels, as well as continue sharing and learning from HbA1C scores, treatments and dosages, in addition to symptoms and severity.

The feature will be launched in early December, PatientsLikeMe said.

November 23, 2011

A test commonly used to identify patients with diabetes or those at risk of developing the condition may not produce accurate results among children, according to a new study conducted by researchers at the University of Michigan.

NEW YORK — A test commonly used to identify patients with diabetes or those at risk of developing the condition may not produce accurate results among children, according to a new study conducted by researchers at the University of Michigan.

The study, published online ahead of print in the journal Diabetes Care, tested 254 overweight children using both fasting and nonfasting methods. Researchers found that the recommended test, hemoglobin A1C (HbA1C), missed more cases of prediabetes or diabetes, compared with other tests.

October 6, 2011

Type 1 diabetics who watch the most television have poorer blood-sugar control on average, according to a study published online Sept. 16 by the American Diabetes Association's journal Diabetes Care.

ALEXANDRIA, Va. — Type 1 diabetics who watch the most television have poorer blood-sugar control on average, according to a study published online Sept. 16 by the American Diabetes Association's journal Diabetes Care.

In the cross-sectional study, self-report questionnaires were used to assess media consumption habits, physical activity and socioeconomic status in 296 children, adolescents and young adults with Type 1 diabetes.

September 27, 2011

There seems to be a significant presence of asthma among children with diabetes, and those with both chronic illnesses have a difficult time controlling their blood-sugar levels, according to new research.

NEW YORK — There seems to be a significant presence of asthma among children with diabetes, and those with both chronic illnesses have a difficult time controlling their blood-sugar levels, according to new research.

September 16, 2011

A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.

LISBON, Portugal — A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.